| Unknown | A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucle NCT05523778 | Peking Union Medical College Hospital | N/A |
| Completed | Clinical Study of 18F-Exendin-4 in Insulinoma NCT07340437 | Sichuan Provincial People's Hospital | — |
| Withdrawn | 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs NCT04915144 | British Columbia Cancer Agency | Phase 2 |
| Unknown | [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients NCT05034783 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Unknown | The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma NCT04979611 | First Affiliated Hospital of Fujian Medical University | Phase 1 |
| Terminated | CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia NCT04452396 | Barts & The London NHS Trust | N/A |
| Unknown | Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulino NCT04185350 | Nanjing First Hospital, Nanjing Medical University | EARLY_Phase 1 |
| Unknown | Application of Raw Corn Starch on Patients With Insulinoma NCT03930368 | Peking Union Medical College Hospital | N/A |
| Recruiting | Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease NCT06725693 | Tianjin Medical University | — |
| Active Not Recruiting | DOTATOC PET/CT for Imaging NET Patients NCT03583528 | British Columbia Cancer Agency | — |
| Withdrawn | Pasireotide in Hyperinsulinemic Hypoglycemia NCT03053284 | Montefiore Medical Center | Phase 2 |
| Completed | Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors NCT02259725 | University of Southern California | Phase 2 |
| Completed | 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH NCT03189953 | Radboud University Medical Center | Phase 1 / Phase 2 |
| Terminated | Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kid NCT02273752 | Emory University | Phase 2 |
| Withdrawn | Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors NCT02108782 | Academic and Community Cancer Research United | Phase 2 |
| Terminated | Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With S NCT02031536 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Unknown | EUS-guided Ethanol Ablation of an Insulinoma NCT02121366 | Guangxi Medical University | N/A |
| Unknown | 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis NCT02560376 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Recruiting | Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma NCT02021604 | Cook Children's Health Care System | Phase 1 |
| Active Not Recruiting | Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors NCT01824875 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Completed | Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors NCT01525082 | Shaheen Shagufta | Phase 2 |
| Completed | Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients NCT00937079 | University Hospital, Basel, Switzerland | — |
| Completed | Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00131911 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors NCT00655655 | Mayo Clinic | Phase 1 |
| Terminated | Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors NCT00084461 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00075439 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Laparoscopy to Remove Pancreatic Tumors (Insulinomas) NCT00005910 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Diagnosing and Treating Low Blood Sugar Levels NCT00001276 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| No Longer Available | 18F-FDOPA PET in Neuroendocrine Tumours NCT02431715 | British Columbia Cancer Agency | — |
| Available | 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypog NCT01916148 | Children's Hospital of Philadelphia | — |